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Abstract—Amperometric biosensors are complex systems and
they require a combination of technologies for their development.
The aim of the present work is to propose a new approach in order
to develop nanostructured biosensors for the real-time detection
of multiple metabolites in cell culture flasks. The fabrication of
five Au working electrodes onto silicon substrate is achieved with
CMOS compatible microtechnology. Each working electrode
presents an area of , so structuration with carbon
nanotubes and specific functionalization are carried out by using
spotting technology, originally developed for microarrays and
DNA printing. The electrodes are characterized by cyclic voltam-
metry and compared with commercially available screen-printed
electrodes. Measurements are carried out under flow conditions,
so a simple fluidic system is developed to guarantee a continuous
flow next to the electrodes. The working electrodes are function-
alized with different enzymes and calibrated for the real-time
detection of glucose, lactate, and glutamate. Finally, some tests
are performed on surnatant conditioned medium sampled from
neuroblastoma cells (NG-108 cell line) to detect glucose and
lactate concentration after 72 hours of cultivation. The developed
biosensor for real-time and online detection of multiple metabo-
lites shows very promising results towards circuits and systems
for cell culture monitoring.
Index Terms—Amperometric sensors, biomarkers, carbon nan-
otubes, cells, electrochemical device.
I. INTRODUCTION
E LECTROCHEMICAL biosensors are complex systemsand consist of heterogeneous components: the electro-
chemical cell, typically with three electrodes; the biological
recognition element; the electronics for carrying out measure-
ments; the fluidics, especially for real-time detection. Moreover,
many works [1], [2] have recently shown that nanomaterials
own very interesting features to enhance sensor performance,
especially in the case of biosensors. Thereby, conventional
techniques sometimes are not suitable to handle the heteroge-
neous blocks of a biosensor, especially when nanomaterials
are also involved. System miniaturization is another issue to
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consider towards the development of integrated systems, so
appropriate tools are required to combine such different tech-
nologies together. The microfabrication of electrodes can be
performed with CMOS compatible technologies, which permits
to integrate in the same chip both electrodes and electronics,
and shrink everything down to the micro-scale. Electrodes can
be made of gold, platinum, or silver by evaporation onto silicon
substrate. Afterwards, the sensing element has to be placed
on the working electrode. The sensing element for biosensors
is typically a protein, which reacts with the target molecule.
The straightforward way to deposit protein on the electrodes
is by drop casting with pipettes. However, the technique is no
longer suitable when electrodes are miniaturized. Thus, we
borrow the spotting technology from the field of microarrays
and DNA printing. Spotting tools enable to handle ultra-low
liquid volume and precisely place drops of in diameter.
Spotting can also help in modifying the electrode surface, for
example by placing nanomaterials. Carbon nanotubes (CNT)
have shown suitable properties for biosensing [3] and they
can be used to this purpose. They have to be in a well-dis-
persed solution for the spotting, and in a non-volatile solvent,
since the spotted volume can be down to 500 pl. Real-time
monitoring requires fresh solution at the electrode surface
and equal concentration between the bulk and the interface:
for all these reasons the fluidic system plays a central role.
Hence, it is also necessary to integrate a fluidic cell next to
the electrodes to create a miniaturized electrochemical cell.
Channels and chamber can be manufactured in different ma-
terials: to this purpose the most used in literature is PDMS
(polydimethylsiloxane), which is biocompatible and presents
several advantages, like polymerization at room temperature
[4] and the possibility to be attached reversibly or irreversibly
onto silicon-based materials by oxygen plasma [5]. However,
it is also possible to use more rigid materials, like methacrylate
combined with o-rings to ensure hermetic enclosure [6].
All the aforementioned steps need to be combined together.
The aim of the present paper is to propose existing technologies
for the development of fully integrated biosensors for cell mon-
itoring. The final goal of our research is to achieve the detection
of multiple metabolites with a single platform that integrates
electrodes, electronics and fluidics for the online and real-time
detection of such compounds in cell culture medium.
II. METABOLITE DETECTION IN CELL CULTURE MEDIUM
Cell analysis demands new tools dedicated to the monitoring
of metabolites involved in cell growth. A better understanding
1932-4545/$31.00 © 2012 IEEE
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of the metabolic variation in cell culture can reveal unknown
mechanisms implied in several diseases. Pharmaceutic research
is also interested in following metabolic processes to estimate
drug efficiency tested in vitro [7]. A further example can be
found in regenerative medicine with stem cells: the poor knowl-
edge about differentiation mechanisms requires novel technolo-
gies to monitor stem cell differentiation to optimize their im-
plant in vivo [8].
Among all the endogenous compounds involved in cell
cycle, glucose and lactate play an important role. Cell cultures
metabolize mostly glucose via the glycolytic pathway and they
produce lactate, which is toxic to animal cells and inhibits
cellular metabolism. For this reason, monitoring glucose con-
sumption enables a more efficient glucose metabolism, while
limiting lactate accumulation in culture medium [9]. Moreover,
glucose consumption is a key indicator of cell activity and can
be correlated to growth rate, cell proliferation or differentia-
tion, and cell population dynamics [10]. In our previous work
[11], we have already shown that it is possible to detect such
metabolites off-line during different cell cycles. When dealing
with neural cell lines, another important compound to take into
account is glutamate, the most important excitatory neurotrans-
mitter in the mammalian central nervous system. Its monitoring
can be fundamental for the investigation of neurological disor-
ders [12]. Moreover, glutamate is also strictly correlated with
glutamine, an important energy and nitrogen source present
in commercially available media [13]. There are other several
interesting compounds to be monitored in cell cultures, like
ethanol, l-amino acids, galactose, etc [14]. To date, the majority
of research on this topic is focused on the development of inte-
grated chips where cells can be inoculated and cultivated [15],
[16]. On the other hand, minimizing interferences with cells is
much more desirable. Few works [17], [18] deal with multiple
detection of metabolites in cell cultures and none of them has
shown the integration of multiple and nanostructured working
electrodes sharing common counter and reference electrodes.
CITSens Bio sensors (C-CIT, Switzerland) are the only device
in the market able to perform real-time cell monitoring, even if
they do not allow multiple detection on the same platform.
In the present research, we use oxidases as sensing element.
This particular protein family generates hydrogen peroxide
when reacting with the target molecule. The use of
this recognition element permits to achieve the monitoring of
different targets with the same detection principles. In fact,
once the oxidase reacts with its specific substrate, hydrogen
peroxide is produced. The electrical detection occurs because
is an electrochemical active species which oxidates
when a DC potential of is applied. Therefore, the
current intensity is proportional to the metabolite concentration
reacting with the enzyme. Such measurements are typically
done by a potentiostat instrument. The main steps for biosensor
fabrication and potentiostat design are considered in the fol-
lowing sections.
III. MICROFABRICATION AND FUNCTIONALIZATION
The detection of multiple targets requires multiple working
electrodes (WEs). We modify WEs by using carbon nanotubes
Fig. 1. Process flow for the microfabrication of the electrochemical cell with
multiple WEs. (a) Photoresist (PR) deposition for Pt electrode patterning.
(b) Cr/Pt/Cr deposition by PVD. (c) Lift-off of the Cr/Pt/Cr. (d) PR deposition
for Au electrode patterning. (e) Lift-off of the Cr/Au/Cr. (f) RF sputtering.
(g) PR deposition and etching of the and Cr layer. (h) PR stripping.
(CNT), since they have specific electronic properties, like good
conductivity [19], high electron transfer rate [14], and consid-
erable electronic emission [20]. These properties result in en-
hanced sensitivities and lower detection limit from the point-of-
view of the biosensor [2], [3]. Then, different protein functional-
ization of WEs will guarantee the multiple detection of metabo-
lites.
A. Microfabrication
The chip is conceived with five working electrodes, in order
to detect up to five different metabolites at the same time. It
consists of gold WEs, whose surface will be modified by CNT
afterwards, gold counter electrode, and platinum reference elec-
trode. A schematic of the microfabrication process is illustrated
in Fig. 1. Metal layers are evaporated by physical vapor depo-
sition (PVD) onto silicon substrate covered by
500 nm of . Au and Pt thin films (200 nm) are patterned to
form the electrodes and connections by photolithography and
lift-off processes. A thin film of Cr (20 nm) is deposited on
top and under the metal layer, as adhesion layer for metals and
passivation. All the WEs are identical and they have an area of
. Connector insulation is achieved by radio-frequency
(RF) sputtering of and successive dry etching by deep re-
active ion-etching (DRIE) of the and wet etching (mixture
of ceric ammonium nitrate and perchloric acid) of Cr etching
next to the electrodes and pads for electronic connections. The
interface between the chip and the potentiostat is guaranteed
by using a commercial edge card socket, while the switching
among the five WEs is achieved by a manual switch in the first
prototype.
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B. CNT Spotting
Multi-walled carbon nanotubes (MWCNT—diameter 10 nm,
length ) are purchased in powder (90% purity) from
Dropsens (Spain). Then, they are dispersed in a solution of dis-
tilled water 50 vv% and ethanol 50 vv%,with 0.5 wt% onNafion
(purchased from Sigma-Aldrich, Switzerland). Final concen-
tration of MWCNT is 1 mg/ml. The Nafion-based solution is
chosen according to the high solubility that carbon nanotubes
showed in the research of Wang et al. [21]. It is preferred to
dispersion in chloroform because it is too volatile for the vol-
umes involved in our study. Automatic spotting of CNT is per-
formed with a commercially available non-contact spotter (sci-
FLEXARRAYER DW by Scienion, Germany). The minimum
dispensed volume is around 400 pl and can be increased by in-
creasing the number of drops per spot. According to previous re-
sults obtained with macroelectrodes [22], we deposit 600 ng of
CNT, corresponding to a volume of 600 nl of MWCNT/Nafion
solution. Drop size is around with the tendency to ag-
gregate. This is due to the fact that walls of carbon nanotubes
are highly hydrophobic. Therefore, we pattern the electrode area
as a matrix of 5 5 spots, to cover the entire electrode. Then,
we dispense 10 drops for each spot (around 4 nl per spot) for 5
cycles. The dimension and the volume of the drops can be mon-
itored at the end of each spotting by using a camera installed
on the instrument. After the Nafion solution is dry, the carbon
nanotubes uniformly cover the electrode surface.
C. Functionalization With Enzymatic Probes
In the present research we show results related to glucose,
lactate, and glutamate detection. However, the same principles
can be used for other metabolite detections. Glucose oxidase
from Aspergillus Niger (GOD, EC 1.1.3.4, 129.9 units/mg
solid), glutaraldehyde solution (25% water), D-(+)-glucose,
lithium L-lactate, and L-glutamic acid were purchased from
Sigma-Aldrich (Switzerland) as lyophilized powders. Gluta-
mate oxidase from Streptomyces species (GlOD, EC 1.4.3.11,
25 units) was supplied from Yamasa Co. (Japan), while lac-
tate oxidase from Pediococcus species (LOD, EC 1.13.12.4,
solid) was purchased from Roche Diagnostics
GmbH (Germany). All the enzymes are dissolved in Phosphate
Buffer Saline solution (PBS) 0.01 M at pH 7.4 and glutaralde-
hyde 0.25% (GOD 50 mg/ml, LOD 66 mg/ml, and GlOD
0.6 U/ml), while metabolites are dissolved in PBS solution or
cell culture medium. For GOD and LOD the enzyme concen-
tration is enough to spot 100 drops for each electrode (5 5
matrix, 4 drops per spot), while GlOD is more diluted, so we
need 1000 drops onto the electrode area (10 10 matrix, 10
drops per spot). Once the enzymes are dropped on the elec-
trode, the proteins are adsorbed onto carbon nanotube walls, as
previously discussed in [11].
D. Cell Culture
NG-108 neuroblastoma cells belong to a neuronal cell line
which exhibits two different morphologies according to the
cell state. They are supplied by Prof. Horst Vogel (EPFL,
Switzerland). Cells are maintained in Dulbecco’s modified
Eagle’s medium ( , Gibco-Invit-
rogen, Switzerland), supplemented with 10% Foetal Bovine
Fig. 2. A schematic of the architecture conceived for the electrochemical mea-
surements of metabolites in cell culture monitoring.
Serum (FBS, Gibco/BRL, Rockville, MD, USA) in
culture flasks (Corning, New York, NY USA) in a 5%
atmosphere at . When reaching 80–90% of confluence
(normally after 48–72 hours of culture), cells are split with
0.05% Trypsin-EDTA (Gibco-Invitrogen, Switzerland) and
seeded in new flasks, while surnatant conditioned medium is
collected for glucose and lactate level measurements [23].
IV. ARCHITECTURAL DESIGN
As previously mentioned, we aim to develop an inte-
grated platform for the monitoring of different metabolites in
cell culture. Electrode fabrication was already described in
Section III-A. In this Section we discuss the electronics needed
to perform electrochemical measurements and we present a
possible design for the potentiostat that is currently under
development. The use of such biosensors for cell cultures
complicates the design, since cells are continuously kept in
the incubator and the system has to be as less invasive as
possible. A wireless communication between the chip and a
remote station is highly desirable, while the user should have
the possibility to remotely choose the metabolite to monitor
and activate the measurement. The proposed architecture under
development is illustrated in Fig. 2.
Electrochemical biosensors require a potentiostat to perform
the measurement. Each oxidase is selective to one specific target
and hydrogen peroxide is generated by the redox reaction.
concentration can be measured by keeping a constant potential
of 650 mV between working and reference electrodes, while no
current is flowing between the two. Due to the applied potential,
is electrolyzed and a current flows through the counter
electrode. The current value is proportional to the substrate con-
centration. The user can remotely choose the metabolite to de-
tect by selecting the appropriate working electrode. The setting
is transmitted to the microcontroller by means of the Bluetooth
module. The microcontroller drives the analog switch to con-
nect the right working electrode.
The potentiostat is conceived in two blocks: the control am-
plifier and the transimpedance amplifier. Referring to Fig. 2,
the control amplifier keeps a constant voltage of 650 mV be-
tween working and reference electrodes. The reference elec-
trode is connected to a voltage follower (OA3); thus, no current
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flows through it. The counter electrode is connected to a tran-
simpedance amplifier (OA4). The virtual short-circuit between
the inputs of OA4 forces a virtual ground on the counter elec-
trode (grounded counter configuration). During the measure-
ment, is open and the current flowing through the working
electrode charges the capacitor C. The slope of the charging
curve is directly proportional to the value of the cur-
rent, accordingly to the expression
The current I is assumed to be constant during the whole charge.
By properly selecting the value of the capacitor C and the in-
tegration time , different ranges of current can be measured.
After every measurement, the capacitor is discharged by closing
the switch . The output voltage of the transimpedance am-
plifier is digitalized and transmitted to a remote station by the
Bluetooth module. The whole system is powered by using stan-
dard batteries to avoid contamination of the cell culture due to
external cables.
V. ONLINE MEASUREMENTS
First we need to characterize the bare electrodes and investi-
gate their properties. Due to the lithographic process, we have
to check that the active area of different electrodes is similar.
To this purpose, we exploit them with cyclic voltammetry (CV),
using ferricyanide, which is a well-known and stable species.
Afterwards, we compare the recorded CV with those obtained
with commercially available screen-printed electrodes (SPE)
(Dropsens, Spain). SPE consists of a gold working electrode
(with area of ), gold counter, and silver reference elec-
trodes. Once the microfabricated electrodes are nanostractured
and functionalized, we proceed with their calibration according
to the enzyme probe. We finally test the biochip in a cell culture
by detecting glucose consumption and lactate production after
72 hours of cultivation. All the electrochemical measurements
are acquired by using Autolab potentiostat system (Metrohom,
Netherlands).
A. Electrode Characterization
Ferricyanide solutions are prepared in the range of
0 – 20 mM in PBS (ferrycianide is purchased in powder
from Sigma-Aldrich, Switzerland). For CV characterization,
electrodes are kept in quiescent conditions by casting a
drop of substrate to cover the whole electrochemical cell. We
perform 10 cycles and we consider the last one, which is the
most stable. Microfabricated electrodes are compared with
commercially available screen-printed electrodes. We repeat
the measurements for several concentrations of ferricyanide for
all the five electrodes. Fig. 3 illustrates an example of cyclic
voltammetry performed on the five WEs for 10 mM of ferri-
cyanide. The CVs overlap for different electrodes and the two
peaks of ferricyanide are well shaped. The average potential for
the oxidation peak is , while is
for reduction peak. Therefore, the difference among different
electrodes is lower than 10% (much lower in the case of oxi-
dation peak). CV is also performed for commercially available
screen-printed electrodes (data not shown). Oxidation peak
Fig. 3. Cyclic voltammograms of 10 mM ferricyanide for the five working
electrodes (scan rate 100 mV/s). Inset: comparison between commercial SPE
and microfabricated electrodes for ferricyanide.
occurs at , with 20 mV shift towards higher
potential with respect to the case of microelectrodes. This is
due to the reference electrodes, which are made of different
materials.
Peak height varies according to substrate concentration for
both SPE and microfabricated electrodes. It is possible to com-
pare the two calibration lines, once they are normalized for the
electrode area. As shown in the inset of Fig. 3, we notice an
almost perfect superimposition of the two lines. Those results
guarantee that microfabricated electrodes are suitable to be used
as electrochemical biosensors.
B. Calibration in PBS for Different Metabolites
Calibrations for the different metabolites are performed
by means of chronoamperometry under flow conditions with
nanostructured and functionalized electrodes. The fluidic
system consists of an inner channel, a chamber, and an outlet
channel molded in PDMS. The curing agent is mixed with
the liquid PDMS in a rate of 1 to 10 and the solution is put
in the desiccation chamber for about 1 hour to pull out all the
air bubble. Then, the fluid is poured in a PMMA (polymethil-
methacrylate) mold and let dry in the oven at for one
hour. Once the fluidic system is solidified, it is kept in oxygen
plasma for 70 seconds with a power of 20 W to increase the
hydrophilicity before using it. The PDMS chamber is then fixed
inside an in-house chip holder made of PMMA to provide easy
connections with the rest of the fluidic system (refer to Fig. 4
for a schematic of the biochip and the in-house holder). The
inner and outlet channels are connected to a peristaltic pump
(Gilson SA, Switzerland) by means of Tygon tubes of 0.25 mm
of internal diameter. The sample solution is circulated with a
velocity of around . Once the measurement is run, we
change the solution at the inlet of the fluidic circuit around every
3 minutes. A current variation occurs on the active working
electrode when the solution is changed. A typical chronoamper-
ometry is depicted in Fig. 5: well-shaped steps are visible every
further injection of substrate. Calibration line is calculated from
current steps, by measuring the difference between the baseline
(related to 0 mM concentration) and the reached value. For
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(a) (b)
Fig. 4. (a) In-house chip holder in PMMA hosting the PDMS chamber and the
biochip with multi-working electrodes. (b) A picture of the fluidic system.
Fig. 5. Typical chronoamperometry for lactate in PBS in the range
within 0 and 1 mM (applied potential ). The arrows point out
the exchange of solution.
lactate the sensitivity results in a value of
and a detection limit of . We
perform chronoamperometries for glucose and glutamate with
the same setup used for lactate (refer to Fig. 6). The sensitivity
for glucose is with a detection limit of
, while for glutamate is
with a detection limit of . Glutamate
biosensor starts responding from , as shown in the inset
of Fig. 6.
C. Metabolite Detection in NG-108 Cell Line
Membranes with proper cut-off can significantly extend the
linear range of a biosensor playing the role of a diffusion barrier.
The drawback is the decrease of the biosensor sensitivity [24].
For these reasons we employ a microdialysis probe as the layer
diffusion barrier. The probe is immersed in the culture medium
and connected with the fluidic system. The experimental setup
appears slightly different for metabolic analysis in cell culture
(a schematic is depicted in Fig. 7). Microdialysis probe consists
of 2 coaxial channels: the outer wall is a membrane, which pore
size is chosen according tomolecule size that wewant to include
in our measurements. A perfusate is flowed through the inner
channel (in our case is PBS) and pushed to pass outside at the
end of the probe. The solution leaving the probe is enriched by
Fig. 6. Calibration lines for the three considered metabolites: glucose
(rhombus), lactate (square), and glutamate in the inset (triangles).
(a) (b)
Fig. 7. (a) Fluidic system for calibration of different metabolites. (b) Working
principles for a microdialysis probe.
molecules, which can diffuse through the outer membrane from
the medium. A schematic of the probe is illustrated in Fig. 7(b).
We use a microdialysis probe (Microbiotech SA, Sweden) with
a cut-off of 6 kDa.We are interested to detect glucose and lactate
for instance, which are small molecules. Glucose has an atomic
mass lower than 200 Da, while lactate has an atomic mass lower
than 100 Da. The second advantage of the microdialysis probe
is the possibility to be sterilized. With a view to the application
in cell culture monitoring, we can avoid contamination even if
the probe is in continuous contact with it.
Lactate production and glucose uptake are normal mecha-
nisms in a cell culture. If neuroblastoma cells are in favorable
conditions, they keep proliferating. As soon as cell number in-
creases, glucose uptake and lactate production becomemore im-
portant. Surnatant conditioned medium is collected from three
different batches of NG-108 cells. We start to detect lactate:
the microdialysis probe is dept in fresh DMEM (without lac-
tate) to measure the baseline. Once the measurement is stable,
the current value is used as a baseline for the following mea-
surements. The fresh medium is changed with DMEM in which
is added lactate (concentration of 10 mM), without stopping
the peristaltic pump and the electrochemical measurement. The
continuous monitoring reveals that current increases according
to the increase of lactate concentration. The two obtained cur-
rent values are used for a further check on the calibration of
the biosensor. After that, the surnatants coming from the first
batch is measured for 5 minutes before the successive sample
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Fig. 8. Measurement of lactate levels in surnatant conditioned medium after
72 hours of NG-108 cell culture. Data are post-processed by using a Butterworth
filter.
TABLE I
LACTATE PRODUCTION IN SURNATANT CONDITIONED MEDIUM
TABLE II
GLUCOSE UPTAKE IN SURNATANT CONDITIONED MEDIUM
to rinse the biochip. The second and the third batches are mea-
sured successively. Lactate concentration results in a value of
in batch 1, in batch 2, and
in batch 3 after 72 hours of cultivation. The
measurement related to batch 2 is depicted in Fig. 8, as an ex-
ample. The detected lactate is quite similar to values reported
from Leegsma-Vogt et al. [25] for NG-108 cell line. We per-
form a similar measurement for glucose in one batch: the base-
line and the current related to a nominal value are registered, as
in the previous experiment. The calibration occurs referring to
the baseline and to a glucose concentration of 22.5 mM, which
is the concentration normally present in the fresh medium added
to cells. The successive measurement, instead, concerns the sur-
natant after 72 hours of cultivation (data not shown). Glucose
uptake can be measured and it results in a value of ,
which is less than half of the initial value of glucose. This is a
further confirmation that cells proliferate and this evidence can
be fundamental to distinguish different cellular states. Data re-
lated to lactate and glucose detection are summarized in Table I
and in Table II, respectively.
VI. CONCLUSION
We described how various heterogeneous technologies can
support the development of electrochemical biosensors for the
detection of multiple metabolites, such as glucose, lactate and
glutamate. We have fabricated a micro-electrochemical cell
with five working electrodes. We have shown that spotting
tools are suitable for nanostructuring and functionalization,
althought they were originally developed for microarrays and
DNA printing. We have presented the design under devel-
opment of the potentiostat for the online monitoring of cell
cultures. We have demonstrated that redox reactions on mi-
crofabricated electrodes are the same as those obtained with
commercially available gold screen-printed electrodes. We
achieved the selective functionalization of the electrodes with
different oxidases and we calibrated under flow conditions
the developed biosensor for glucose, lactate and glutamate
detection. We obtained a sensitivity of
and a detection limit of for lactate, a sensitivity of
and a detection limit of for glucose,
a sensitivity of and a detection limit of
for glutamate. We tested our carbon nanotubes-based
biosensor in a neural cell culture and we detected glucose and
lactate in surnatant conditioned medium. Data show lactate
production and glucose uptake after 72 hours of cultivation.
The present results are really promising towards the online
application of such biosensors for the real-time monitoring
of multiple metabolites in cell cultures. Few works deal with
metabolite detection in cell cultures. However, none of them
has shown the integration of multiple and nanostructured WEs
sharing common counter and reference electrodes. Instead, data
showed in the present paper represent a novelty with respect to
the state-of-the-art in cell culture monitoring and pave the way
to new integrated systems for cell analysis.
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